Lung cancer vaccine trials launched: What you need to know about BNT116
In a significant breakthrough, the world’s first mRNA lung cancer vaccine trials have been launched across seven countries, ...
pharmaphorum3y
BioNTech takes its first cancer vaccine into phase 2
It would be easy to forget that back in 2019, BioNTech was an early-stage biotech firmly focused on cancer vaccines, before being catapulted onto the world-stage with its COVID-19 shot.
BioNTech reports FDA clinical hold on Phase I/IIa trial of BNT165e
In a regulatory filing, BioNTech (BNTX) disclosed that the U.S. Food and Drug Administration has informed BioNTech SE that it has placed a ...
pharmaphorum1y
ESMO: Can BioNTech’s revved-up CAR-T hit solid tumours?
At ESMO, the mRNA specialist reported updated results from its phase 1/2 trial of its lead candidate BNT-211, which consists of a CAR-T directed at Claudin-6 coupled with an mRNA vaccine (CARVac ...